Transaction details
Emily Rollins, serving on the board of Dolby Laboratories, Inc. (NASDAQ: DLB), sold 1,000 shares of the companys Class A common stock on April 1, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares traded at $60.08 apiece, producing a total sale amount of $60,080. The filing was signed by Daniel Rodriguez acting as Attorney-in-Fact for Rollins and is dated April 3, 2026.
Post-transaction holdings and vesting status
Following the disposition, Rollins directly owns 12,541 shares of Dolby Laboratories common stock. That total includes 3,908 shares that are underlying restricted stock units; those restricted units remain subject to forfeiture until they vest according to company grant terms.
Market context and valuation note
At the time of the report, Dolby shares were trading at $61.79. Separate analysis from InvestingPro cited in the filing materials indicates the stock appears undervalued based on Fair Value calculations.
Recent company performance
Dolby Laboratories reported first-quarter 2026 results showing adjusted earnings per share of $1.06, compared with analyst expectations of $0.88, representing a 20.45% positive surprise. Revenue in the period was $347 million versus forecasts of $332.07 million. The companys outperformance on these measures was highlighted in the disclosure as evidence of its ability to exceed market expectations.
Analyst and investor implications
The filing notes that these financial results may prompt analysts to revisit models and evaluations. While the disclosure does not identify specific firms or projected changes, it indicates that some analysts are likely to adjust their assessments in response to the quarter's stronger-than-expected metrics. Investors seeking additional context are directed to a Pro Research Report available on InvestingPro for deeper analysis.
This report presents the transaction information filed with the SEC and the companys reported quarterly results. It does not offer an opinion on investment decisions but summarizes disclosed insider activity and the companys recent financial performance.